TOMZ TOMI Environmental Solutions, Inc.
Industrial Organic Chemicals · Nasdaq · SEC CIK 314227 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY30.3%
TTM net income YoY38.7%
TTM EPS YoY82.2%
Revenue 3-yr CAGR-5.0%
Net income 3-yr CAGR—
Margins
Gross margin52.7%
Operating margin-33.5%
Net margin-43.0%
FCF margin-29.6%
EBITDA margin-28.7%
Returns
ROE-102.5%
ROA-37.8%
ROIC (approx.)-63.7%
Asset turnover0.88x
Leverage & solvency
Liabilities / assets54.6%
Debt / equity0.16x
Current ratio1.49x
Interest coverage-9.52x
Cash quality & payout
Operating cash flow / net income0.68x
Accruals ratio-12.0%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $5.64M | $7.74M |
| Cost of revenue | $2.56M | $4.18M |
| Gross profit | $3.08M | $3.56M |
| R&D expense | $289,899 | $290,683 |
| SG&A expense | $4.53M | $5.12M |
| Operating income | -$3.85M | -$4.10M |
| Interest expense | $356,675 | $312,000 |
| Pretax income | -$3.75M | -$4.48M |
| Income tax | $0 | $0 |
| Net income | -$3.75M | -$4.48M |
| EBITDA | -$3.58M | -$3.81M |
| EPS (basic) | -0.19 | -0.22 |
| EPS (diluted) | -0.19 | -0.22 |
| Weighted avg. shares (diluted) | 20.09M | 19.99M |
| Banking | ||
| Deposits | $161,597 | $35,895 |
| Balance sheet | ||
| Cash & equivalents | $87,775 | $664,879 |
| Receivables | $689,153 | $1.88M |
| Inventory | $2.93M | $3.58M |
| Current assets | $4.19M | $6.49M |
| PP&E, net | $614,311 | $875,449 |
| Intangibles | $1.35M | $1.25M |
| Total assets | $7.03M | $9.69M |
| Current liabilities | $3.16M | $2.72M |
| Short-term debt | $143,672 | $129,132 |
| Long-term debt | $3.13M | — |
| Total debt | $3.28M | — |
| Total liabilities | $6.45M | $5.59M |
| Shareholders' equity | $588,504 | $4.10M |
| Net debt | $3.19M | — |
| Shares outstanding | 6.76M | 20.02M |
| Cash flow statement | ||
| Operating cash flow | -$1.20M | -$1.44M |
| Capital expenditure | $5,165 | $107,891 |
| Free cash flow | -$1.20M | -$1.55M |
| Investing cash flow | -$135,577 | -$261,527 |
| Financing cash flow | $755,125 | $27,500 |
| Depreciation & amortization | $271,329 | $296,536 |
| Stock-based compensation | $147,000 | $144,307 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.